Digitisation | August 21, 2025
Dr. Lal PathLabs pioneers AI integration in cancer diagnosis in India
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
Skyhawk Therapeutics enters into an option agreement to grant Merck KGaA, Darmstadt, Germany, exclusive global rights to drug candidates pursued under the collaboration upon option exercise
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
This system enables comprehensive diagnosis of both acid and non-acid reflux, along with esophageal motility disorders.
The CRDMO segment contributed Rs. 452.7 crore, recording a robust 70.5 per cent YoY increase
The technology offers scalable continuous granulation at 200 kg/hour, with the potential to exceed 500 kg/hour for certain granules
Alkem’s domestic business grew 9.7 per cent versus the Indian pharmaceutical market growth of 8.5 per cent
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
Subscribe To Our Newsletter & Stay Updated
